Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
58,749
-0.03%
|
$53,755,335
$915.73 P/Share
|
|
Jun 28
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
1,441
-0.0%
|
$1,318,515
$915.02 P/Share
|
|
Jun 25
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
188,100
-0.02%
|
$170,230,500
$905.89 P/Share
|
|
Jun 24
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
17,229
-0.01%
|
$15,540,558
$902.86 P/Share
|
|
Jun 20
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
9,671
-0.0%
|
$8,732,913
$903.33 P/Share
|
|
Jun 17
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.41%
|
$9,735
$885.01 P/Share
|
|
Jun 17
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.11%
|
$15,045
$885.01 P/Share
|
|
Jun 17
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.51%
|
$9,735
$885.01 P/Share
|
|
Jun 17
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.02%
|
$11,505
$885.01 P/Share
|
|
Jun 17
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.73%
|
$9,735
$885.01 P/Share
|
|
Jun 17
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
194,978
-0.02%
|
$172,945,486
$887.47 P/Share
|
|
Jun 14
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
15,022
-0.01%
|
$13,249,404
$882.83 P/Share
|
|
Jun 10
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
75,510
-0.0%
|
$65,014,110
$861.15 P/Share
|
|
Jun 07
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
139,490
-0.02%
|
$118,984,970
$853.93 P/Share
|
|
Jun 06
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
179,617
-0.02%
|
$151,057,897
$841.49 P/Share
|
|
Jun 05
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
20,383
-0.01%
|
$17,040,188
$836.9 P/Share
|
|
Jun 03
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
192,794
-0.01%
|
$160,019,020
$830.28 P/Share
|
|
Jun 03
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
750
-9.52%
|
$614,250
$819.47 P/Share
|
|
Jun 03
2024
|
Johna Norton EVP, Global Quality |
SELL
Open market or private sale
|
Direct |
7,056
-21.72%
|
$5,778,864
$819.38 P/Share
|
|
Jun 01
2024
|
Diogo Rau EVP & CIDO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,045
-21.53%
|
$2,496,900
$820.34 P/Share
|
|
Jun 01
2024
|
Diogo Rau EVP & CIDO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,300
+30.81%
|
-
|
|
May 31
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
22,206
-0.01%
|
$18,253,332
$822.63 P/Share
|
|
May 29
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
130,385
-0.02%
|
$105,872,620
$812.44 P/Share
|
|
May 28
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
2,052
-0.0%
|
$1,660,068
$809.0 P/Share
|
|
May 24
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
92,563
-0.09%
|
$74,883,467
$809.21 P/Share
|
|
May 23
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
50,767
-0.0%
|
$41,222,804
$812.27 P/Share
|
|
May 22
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,974
-0.01%
|
$10,431,096
$804.18 P/Share
|
|
May 21
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
186,259
-0.02%
|
$150,497,272
$808.57 P/Share
|
|
May 20
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.6%
|
$10,179
$783.18 P/Share
|
|
May 20
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.86%
|
$10,179
$783.18 P/Share
|
|
May 20
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.45%
|
$9,396
$783.18 P/Share
|
|
May 20
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,877
$783.18 P/Share
|
|
May 20
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,745
$783.18 P/Share
|
|
Apr 15
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.61%
|
$9,750
$750.77 P/Share
|
|
Apr 15
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$12,000
$750.77 P/Share
|
|
Apr 15
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.87%
|
$9,750
$750.77 P/Share
|
|
Apr 15
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.49%
|
$9,750
$750.77 P/Share
|
|
Apr 15
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.13%
|
$15,000
$750.77 P/Share
|
|
Mar 18
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
19
+0.12%
|
$14,478
$762.66 P/Share
|
|
Mar 18
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.61%
|
$9,906
$762.66 P/Share
|
|
Mar 18
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.03%
|
$11,430
$762.66 P/Share
|
|
Mar 18
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.88%
|
$9,906
$762.66 P/Share
|
|
Mar 18
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.49%
|
$9,906
$762.66 P/Share
|
|
Mar 11
2024
|
Donald A Zakrowski SVP, Finance, & CAO |
SELL
Open market or private sale
|
Direct |
750
-8.69%
|
$564,750
$753.6 P/Share
|
|
Feb 20
2024
|
Mary Lynne Hedley Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.89%
|
$9,815
$755.66 P/Share
|
|
Feb 20
2024
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.62%
|
$9,815
$755.66 P/Share
|
|
Feb 20
2024
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.13%
|
$15,100
$755.66 P/Share
|
|
Feb 20
2024
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$12,080
$755.66 P/Share
|
|
Feb 20
2024
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.5%
|
$9,815
$755.66 P/Share
|
|
Feb 16
2024
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
169,684
-0.01%
|
$132,014,152
$778.8 P/Share
|